Alp Bugra Basat, M.D.
CEO and Director
Dr. Basat received his M.D. degree from Hacettepe University of Ankara, Turkey, and worked in several laboratories and clinics at Harvard Medical School and University of Oxford. Dr. Basat also worked as an associate at Rhea Capital Partners. He completed his post-doctoral research at University of California San Diego, working on adenosine receptors, sympathetic nerves and hypertension.
Ms. Dich's professional experience includes nearly 18 years of healthcare and industry clinical and translational R&D in cardiovascular/ metabolic disorders, oncology, immunology, dermatology, and rare disease. Her career started with the creation of NYC Health and Hospitals Corporation’s Clinical and Health Service Research Department, and she has gone on to author numerous drug related applications. Ms. Dich earned her Bachelor’s degree in Psychology with a focus on cognitive-behavioral psychology from Long Island University, NY. She later completed her Masters of Science in Health Sciences, concentration on experimental design, from George Washington University, DC.
John Alan Tucker, Ph.D.
Medicinal Chemistry Advisor
Dr. Tucker received his Ph.D. in chemistry in 1987 in the research group of Nobel Laureate Donald Cram, and went on to earn his MBA from the Anderson School of Management at UCLA in 2009. He has spent more than 20 years in the pharmaceutical industry and has worked as a group leader at a variety of prestigious pharmaceutical companies including ChemBridge Research Laboratories, Elan, and Pfizer.